Low molecular weight heparin (FRagmin) in pregnant women with a history of Uteroplacental Insufficiency and Thrombophilia: a randomised trial.

Trial Profile

Low molecular weight heparin (FRagmin) in pregnant women with a history of Uteroplacental Insufficiency and Thrombophilia: a randomised trial.

Completed
Phase of Trial: Phase III

Latest Information Update: 01 Feb 2016

At a glance

  • Drugs Aspirin; Dalteparin sodium
  • Indications Fetal growth retardation; Preeclampsia; Pregnancy; Thrombophilia
  • Focus Therapeutic Use
  • Acronyms FRUIT
  • Most Recent Events

    • 08 May 2012 New source identified and integrated (Netherlands Trial Register; NTR337).
    • 25 Nov 2011 Results published in the Journal of Thrombosis and Haemostasis.
    • 09 Jan 2010 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top